Mieloproliferatív neopláziák: vizsgálatok itt: Brazília
5 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
- Where
- Barretos, Curitiba, Florianópolis, Goiânia
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07357727 · EU 2025-523555-66-00 - 4. fázisBefejeződöttAsciminib Roll-over Study
- Where
- Rio de Janeiro, São Paulo
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 3. fázisNot yet taking people in BrazíliaA Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Where
- Florianópolis, Jaú, Joinville, Porto Alegre, Rio de Janeiro, São Paulo
- Életkor
- 18 év and over
- People
- 324 worldwide
- Run by
- Takeda
See details and how to joinNCT07623161 · EU 2026-525660-17-00 - 3. fázisTaking peopleINTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
- Where
- Belém, Blumenau, Santa Catarina
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT07429266 · EU 2025-524669-25-00 - 2. fázisTaking peopleA Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
- Where
- Porto Alegre, São Paulo
- Életkor
- 18 év and over
- People
- 135 worldwide
- Run by
- Takeda
See details and how to joinNCT05037760 · EU 2023-507468-38-00